Conference item
Results of a phase 2 trial of the monocyte-targeted histone deacetylase inhibitor tefinostat (CHR-2845) in chronic myelomonocytic leukemia (CMML) - the UK monocle study
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Authors
- Publisher:
- American Society of Hematology
- Host title:
- Blood
- Journal:
- Blood More from this journal
- Volume:
- 132
- Issue:
- Supplement 1
- Article number:
- 1818
- Publication date:
- 2018-11-29
- Acceptance date:
- 2018-10-01
- DOI:
- EISSN:
-
1528-0020
- ISSN:
-
0006-4971
- Keywords:
- Pubs id:
-
pubs:980216
- UUID:
-
uuid:e35941a5-9c66-446f-8191-bea12e5e9400
- Local pid:
-
pubs:980216
- Source identifiers:
-
980216
- Deposit date:
-
2019-04-04
Terms of use
- Copyright date:
- 2018
- Notes:
- © 2018 by The American Society of Hematology. This paper was presented at the 60th ASH Annual Meeting, 1-4 December 2018, San Diego, CA, USA.
If you are the owner of this record, you can report an update to it here: Report update to this record